Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
130 participants
OBSERVATIONAL
2015-03-01
2016-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Human Sodium Balance Study
NCT04110262
Food and Salt Handling in Diuresis
NCT04526340
Study With an Innovative Equipment to Monitor and Control SALT During Cooking
NCT03974477
The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Healthy Humans.
NCT00345215
Sodium Sources and Sodium Intake in a Representative Sample of Spanish Children
NCT03465657
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Urinary sodium excretion
Urinary sodium and potassium were measured using the Ion-Selective Electrode (ISE) indirect Na-K-Cl for Gen.2 (Roche Diagnostic, Switzerland).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* unable to provide 24-hr urine excretion sample
* those with a known history of heart or kidney failure, stroke, and liver disease
* those using diuretics, multivitamins, NSADs, or prostaglandins during the last two weeks
* pregnant women
25 Years
64 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad San Francisco de Quito
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ivan Sisa
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Enrique Teran, MD, PhD
Role: STUDY_DIRECTOR
Universidad San Francisco de Quito
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUBI-1022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.